Diagnosis
Insulin-like growth factor binding protein 7 as a candidate biomarker for systemic sclerosis
Y.-M. Yan1, J.-N. Zheng2, Y. Li3, Q.-R. Yang4, W.-Q. Shao5, Q. Wang6
- Department of Dermatology, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Dermatology, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Stomatology, Zhongshan Hospital, Fudan University, Shanghai, and State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, China.
- Department of Dermatology, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Dermatology, Zhongshan Hospital, Fudan University, Shanghai, China. wangqiang7766@163.com
CER13455
2021 Vol.39, N°4 ,Suppl.131
PI 0066, PF 0076
Diagnosis
Free to view
(click on article PDF icon to read the article)
PMID: 33253093 [PubMed]
Received: 15/04/2020
Accepted : 31/08/2020
In Press: 17/11/2020
Published: 28/07/2021
Abstract
OBJECTIVES:
Systemic sclerosis (SSc) is an autoimmune disease clinically characterised by skin and internal organs fibrosis with high mortality. However, the pathogenesis of SSc is still controversial and the effect of the current treatment is far from satisfactory. We aimed to find out novel candidate genes related to the pathological process in SSc.
METHODS:
In this study, the weighted correlation network analysis (WGCNA) was conducted to identify the key module and hub genes most related to SSc in GSE58095, a microarray dataset from the Gene Expression Omnibus (GEO) database. Also, the key module was analysed by Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. Then we validated hub genes in other datasets (GSE32413, GSE125362, GSE45485, GSE76885, GSE95065). The serum of 37 patients with SSc and 25 healthy control subjects (HCs) were recruited and detected by Enzyme-Linked Immunosorbent Assay (ELISA).
RESULTS:
Five interested genes (IGFBP7, LRRC32, STMN2, C1QTNF5, CPXM1) were up-regulated in SSc microarray datasets from the GEO. And the level of serum IGFBP7, which encodes a secreted protein, was upregulated in SSc patients-also in dcSSc patients and SSc with ILD patients.
CONCLUSIONS:
Among the five interested genes, the IGFBP7 was a novel candidate gene for SSc and may be served as potential target and early biomarker for accurate treatment, which also provides further insights into the pathogenesis of SSc at the molecular level.
